692 related articles for article (PubMed ID: 25732737)
1. Induced Stem Cells as a Novel Multiple Sclerosis Therapy.
Xie C; Liu YQ; Guan YT; Zhang GX
Curr Stem Cell Res Ther; 2016; 11(4):313-20. PubMed ID: 25732737
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of induced neural stem cells (iNSCs) into chronically demyelinated corpus callosum ameliorates motor deficits.
Sullivan GM; Knutsen AK; Peruzzotti-Jametti L; Korotcov A; Bosomtwi A; Dardzinski BJ; Bernstock JD; Rizzi S; Edenhofer F; Pluchino S; Armstrong RC
Acta Neuropathol Commun; 2020 Jun; 8(1):84. PubMed ID: 32517808
[TBL] [Abstract][Full Text] [Related]
3. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intracerebral transplantation effects of different stem cells on rodent stroke models.
Wu Y; Wu J; Ju R; Chen Z; Xu Q
Cell Biochem Funct; 2015 Jun; 33(4):174-82. PubMed ID: 25914321
[TBL] [Abstract][Full Text] [Related]
5. Modelling multiple sclerosis using induced pluripotent stem cells.
MartÃnez-Larrosa J; Matute-Blanch C; Montalban X; Comabella M
J Neuroimmunol; 2020 Dec; 349():577425. PubMed ID: 33130461
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of somatic cells to induced neural stem cells.
Shahbazi E; Mirakhori F; Ezzatizadeh V; Baharvand H
Methods; 2018 Jan; 133():21-28. PubMed ID: 28939501
[TBL] [Abstract][Full Text] [Related]
7. Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications.
Erharter A; Rizzi S; Mertens J; Edenhofer F
FEBS Lett; 2019 Dec; 593(23):3353-3369. PubMed ID: 31663609
[TBL] [Abstract][Full Text] [Related]
8. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
[TBL] [Abstract][Full Text] [Related]
9. Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
Lin L; Bolund L; Luo Y
Curr Stem Cell Res Ther; 2016; 11(2):122-30. PubMed ID: 26201862
[TBL] [Abstract][Full Text] [Related]
10. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
Barati S; Tahmasebi F; Faghihi F
Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244
[TBL] [Abstract][Full Text] [Related]
11. Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.
Abbasi-Kangevari M; Ghamari SH; Safaeinejad F; Bahrami S; Niknejad H
Front Immunol; 2019; 10():238. PubMed ID: 30842772
[TBL] [Abstract][Full Text] [Related]
12. Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.
Xiao J; Yang R; Biswas S; Zhu Y; Qin X; Zhang M; Zhai L; Luo Y; He X; Mao C; Deng W
Mol Neurobiol; 2018 Apr; 55(4):3152-3171. PubMed ID: 28466274
[TBL] [Abstract][Full Text] [Related]
13. Generation of Mesenchymal Stem Cells by Blood Cell Reprogramming.
Chen W; Baylink DJ; Lau KH; Zhang XB
Curr Stem Cell Res Ther; 2016; 11(2):114-21. PubMed ID: 26027679
[TBL] [Abstract][Full Text] [Related]
14. Methods of reactivation and reprogramming of neural stem cells for neural repair.
Tian Z; Zhao Q; Biswas S; Deng W
Methods; 2018 Jan; 133():3-20. PubMed ID: 28864354
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
16. Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.
Yamashita T; Abe K
Cell Transplant; 2014; 23(4-5):435-9. PubMed ID: 24621988
[TBL] [Abstract][Full Text] [Related]
17. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
18. Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases.
Sugai K; Fukuzawa R; Shofuda T; Fukusumi H; Kawabata S; Nishiyama Y; Higuchi Y; Kawai K; Isoda M; Kanematsu D; Hashimoto-Tamaoki T; Kohyama J; Iwanami A; Suemizu H; Ikeda E; Matsumoto M; Kanemura Y; Nakamura M; Okano H
Mol Brain; 2016 Sep; 9(1):85. PubMed ID: 27642008
[TBL] [Abstract][Full Text] [Related]
19. Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases.
Shen T; Pu J; Zheng T; Zhang B
Neurosci Bull; 2015 Oct; 31(5):589-600. PubMed ID: 26077704
[TBL] [Abstract][Full Text] [Related]
20. Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming.
Abdal Dayem A; Lee SB; Kim K; Lim KM; Jeon TI; Seok J; Cho AS
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
